Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:13:15 EDT Sun 12 Apr 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

V:RKV - Rakovina Therapeutics Inc. - https://www.rakovinatherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RKV - V  25.00.09·0.1211.00.11+0.0110.029.42250.11  0.11  0.090.84  0.08515:57:53Mar 2315 min RT 2¢
TSX-V - V25.00.09·0.1211.00.095-0.005-5.08.5130.10  0.10  0.0950.84  0.08512:36:1315 min
NEO ATS - U 0.105.5030.10  0.10  0.09512:36:1315 min
Alpha - A 0.11+0.0110.02.040.11  0.11  0.09515:57:5315 min
Omega - O 0.09-0.01-10.06.0080.11  0.11  0.0912:36:1315 min
CXC - X 0.105.0110.10  0.10  0.1012:36:1315 min
CX2 - H 0.095-0.005-5.02.0020.095  0.095  0.09512:36:1315 min
CXD - D 0.100.43    Mar 2515 min
MatchNOW - M 0.100.021    15 min

Recent Trades - Last 10 of 25
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:57:53A0.110.0150014 Virtu ITG33 CanaccordK
15:50:25A0.110.0150014 Virtu ITG33 CanaccordK
15:30:29D0.110.011280 National Bank14 Virtu ITGE
14:16:05D0.110.0126180 National Bank2 RBCE
12:36:13O0.09-0.011,0001 Anonymous79 CIBCK
12:36:13A0.095-0.00550014 Virtu ITG79 CIBCK
12:36:13H0.095-0.0055007 TD Sec79 CIBCK
12:36:13H0.095-0.0051,5002 RBC79 CIBCK
12:36:13O0.095-0.00550014 Virtu ITG79 CIBCK
12:36:13U0.095-0.00550014 Virtu ITG79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-03-23 04:00C:RKV0.10News ReleaseRakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 - World's Premier Cancer Research Forum
2026-03-12 23:37C:RKV0.13News ReleaseRakovina receives 30-day extension for financing
2026-03-05 20:50C:RKV0.15News ReleaseRakovina closes $1-million debenture unit financing
2026-02-20 20:02C:RKV0.15News ReleaseRakovina Therapeutics increases financing
2026-02-04 10:13C:RKV0.185News ReleaseRakovina talks inbound interest for kt-3000
2026-01-29 21:49C:RKV0.18Private Placement - DebentureRakovina Therapeutics debentures extended
2026-01-27 19:27C:RKV0.18News ReleaseRakovina Therapeutics appoints Oishi as CEO, director
2026-01-08 10:50C:RKV0.11News ReleaseRakovina signs new deal with Variational AI
2025-12-17 04:00C:RKV0.095News ReleaseRakovina Therapeutics Management to Attend Partnering Meetings During JPM Week, January in San Francisco, California
2025-12-10 10:51C:RKV0.12News ReleaseRakovina to host webinar with Variational AI on Dec. 17
2025-12-04 17:30C:RKV0.12Private Placement - DebentureRakovina Therapeutics debentures amended
2025-12-01 15:37C:RKV0.12News ReleaseRakovina's Q3 R&D expenses at $1.1-million
2025-11-28 20:31C:RKV0.12News ReleaseRakovina debentureholders consent to maturity extension
2025-11-28 17:10C:RKV0.12SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-28 17:10C:RKV0.12SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-24 12:44C:RKV0.135News ReleaseRakovina talks ATR/mTOR dual inhibitor preclinical data
2025-11-24 06:00C:RKV0.125News ReleaseRakovina Therapeutics Inc. Announces Presentation of Second Abstract at the 2025 Society for Neuro-Oncology Annual Meeting
2025-11-10 13:26C:RKV0.17News ReleaseRakovina Therapeutics to Present New Data Highlighting CNS-Penetrant ATR and PARP1 Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting
2025-10-27 04:00C:RKV0.27News ReleaseRakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference
2025-10-16 04:00C:RKV0.285News ReleaseRakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference